JP2003529317A5 - - Google Patents

Download PDF

Info

Publication number
JP2003529317A5
JP2003529317A5 JP2000589692A JP2000589692A JP2003529317A5 JP 2003529317 A5 JP2003529317 A5 JP 2003529317A5 JP 2000589692 A JP2000589692 A JP 2000589692A JP 2000589692 A JP2000589692 A JP 2000589692A JP 2003529317 A5 JP2003529317 A5 JP 2003529317A5
Authority
JP
Japan
Prior art keywords
seq
approximately
sequence
pro866
pcr primer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000589692A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003529317A (ja
JP3993746B2 (ja
Filing date
Publication date
Priority claimed from PCT/US1999/005028 external-priority patent/WO1999046281A2/en
Priority claimed from PCT/US1999/021547 external-priority patent/WO2000015797A2/en
Priority claimed from PCT/US1999/021090 external-priority patent/WO2000015796A2/en
Application filed filed Critical
Priority claimed from PCT/US1999/028565 external-priority patent/WO2000037638A2/en
Publication of JP2003529317A publication Critical patent/JP2003529317A/ja
Publication of JP2003529317A5 publication Critical patent/JP2003529317A5/ja
Application granted granted Critical
Publication of JP3993746B2 publication Critical patent/JP3993746B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000589692A 1998-12-22 1999-12-02 腫瘍性細胞成長阻害のための組成物及び方法 Expired - Fee Related JP3993746B2 (ja)

Applications Claiming Priority (19)

Application Number Priority Date Filing Date Title
US11329698P 1998-12-22 1998-12-22
US60/113,296 1998-12-22
PCT/US1999/005028 WO1999046281A2 (en) 1998-03-10 1999-03-08 Novel polypeptides and nucleic acids encoding the same
US9905028 1999-03-08
US13023299P 1999-04-21 1999-04-21
US60/130,232 1999-04-21
US13144599P 1999-04-28 1999-04-28
US60/131,445 1999-04-28
US13428799P 1999-05-14 1999-05-14
US60/134,287 1999-05-14
US14475899P 1999-07-20 1999-07-20
US60/144,758 1999-07-20
US14569899P 1999-07-26 1999-07-26
US60/145,698 1999-07-26
US9921547 1999-09-15
PCT/US1999/021547 WO2000015797A2 (en) 1998-09-17 1999-09-15 Compositions and methods for the treatment of immune related diseases
US9921090 1999-09-15
PCT/US1999/021090 WO2000015796A2 (en) 1998-09-16 1999-09-15 Secreted and transmembrane polypeptides and nucleic acids encoding the same
PCT/US1999/028565 WO2000037638A2 (en) 1998-12-22 1999-12-02 Methods and compositions for inhibiting neoplastic cell growth

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2005066569A Division JP4037876B2 (ja) 1998-12-22 2005-03-10 腫瘍性細胞成長阻害のための組成物及び方法
JP2005066570A Division JP2005237383A (ja) 1998-12-22 2005-03-10 腫瘍性細胞成長阻害のための組成物及び方法

Publications (3)

Publication Number Publication Date
JP2003529317A JP2003529317A (ja) 2003-10-07
JP2003529317A5 true JP2003529317A5 (cg-RX-API-DMAC7.html) 2004-12-24
JP3993746B2 JP3993746B2 (ja) 2007-10-17

Family

ID=27557838

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2000589692A Expired - Fee Related JP3993746B2 (ja) 1998-12-22 1999-12-02 腫瘍性細胞成長阻害のための組成物及び方法
JP2005066569A Expired - Lifetime JP4037876B2 (ja) 1998-12-22 2005-03-10 腫瘍性細胞成長阻害のための組成物及び方法
JP2005066570A Withdrawn JP2005237383A (ja) 1998-12-22 2005-03-10 腫瘍性細胞成長阻害のための組成物及び方法
JP2007138468A Pending JP2007222180A (ja) 1998-12-22 2007-05-24 腫瘍性細胞成長阻害のための組成物及び方法
JP2007138469A Pending JP2007291116A (ja) 1998-12-22 2007-05-24 腫瘍性細胞成長阻害のための組成物及び方法

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2005066569A Expired - Lifetime JP4037876B2 (ja) 1998-12-22 2005-03-10 腫瘍性細胞成長阻害のための組成物及び方法
JP2005066570A Withdrawn JP2005237383A (ja) 1998-12-22 2005-03-10 腫瘍性細胞成長阻害のための組成物及び方法
JP2007138468A Pending JP2007222180A (ja) 1998-12-22 2007-05-24 腫瘍性細胞成長阻害のための組成物及び方法
JP2007138469A Pending JP2007291116A (ja) 1998-12-22 2007-05-24 腫瘍性細胞成長阻害のための組成物及び方法

Country Status (13)

Country Link
EP (1) EP1141284A2 (cg-RX-API-DMAC7.html)
JP (5) JP3993746B2 (cg-RX-API-DMAC7.html)
KR (1) KR100499600B1 (cg-RX-API-DMAC7.html)
AT (2) ATE353339T1 (cg-RX-API-DMAC7.html)
AU (1) AU768230B2 (cg-RX-API-DMAC7.html)
CA (1) CA2353799A1 (cg-RX-API-DMAC7.html)
DE (2) DE69940964D1 (cg-RX-API-DMAC7.html)
DK (1) DK1484338T3 (cg-RX-API-DMAC7.html)
ES (2) ES2327785T3 (cg-RX-API-DMAC7.html)
IL (3) IL143031A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA01006330A (cg-RX-API-DMAC7.html)
PT (1) PT1484338E (cg-RX-API-DMAC7.html)
WO (1) WO2000037638A2 (cg-RX-API-DMAC7.html)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6808890B2 (en) 1999-07-28 2004-10-26 Nuvelo, Inc. Method of detecting a cancerous cell expressing EGFL6, and EGF mutif protein
US6392019B1 (en) 1997-11-22 2002-05-21 John Ford Antibodies specific for EGF motif proteins
US7192589B2 (en) * 1998-09-16 2007-03-20 Genentech, Inc. Treatment of inflammatory disorders with STIgMA immunoadhesins
US7419663B2 (en) 1998-03-20 2008-09-02 Genentech, Inc. Treatment of complement-associated disorders
US8088386B2 (en) 1998-03-20 2012-01-03 Genentech, Inc. Treatment of complement-associated disorders
US8007798B2 (en) 1997-11-21 2011-08-30 Genentech, Inc. Treatment of complement-associated disorders
AU763012B2 (en) 1997-11-22 2003-07-10 Arca Biopharma, Inc. A novel EGF motif protein obtained from a cDNA library of fetal liver-spleen
NZ528700A (en) * 1998-04-08 2005-02-25 Genentech Inc Novel PRO866 polypeptides and nucleic acids with homology to mindin and spondin proteins
CA2331154A1 (en) 1998-06-16 1999-12-23 Human Genome Sciences, Inc. Polypeptides having sequence identity with acid labile subunit of insulin-like growth factor
US6960433B1 (en) 1998-10-19 2005-11-01 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
EA004590B1 (ru) 1999-01-15 2004-06-24 Байоджен, Инк. Способ блокировки развития, или снижения тяжести, или проявлений заболевания "трасплантат против хозяина"
JP2003531811A (ja) * 1999-03-08 2003-10-28 ジェネンテック・インコーポレーテッド 血管形成及び心臓血管新生の促進又は阻害
ATE368110T1 (de) * 1999-07-20 2007-08-15 Genentech Inc Zusammensetzung und verfahren zur behandlung von immunverwandten krankheiten
HUP0203408A3 (en) * 1999-12-09 2005-01-28 Sankyo Co Method of testing remedy or preventive for hyperlipemia
US7119165B2 (en) 2000-01-12 2006-10-10 Yale University Nogo receptor-mediated blockade of axonal growth
HUP0203863A3 (en) * 2000-01-12 2008-03-28 Univ Yale Nogo receptor-mediated blockade of axonal growth
US6943146B2 (en) 2000-05-08 2005-09-13 Biogen Idec Ma Inc. Method for promoting neovascularization
US7208151B2 (en) 2001-09-12 2007-04-24 Biogen Idec Ma Inc. Tweak receptor agonists as anti-angiogenic agents
ES2341608T3 (es) 2000-10-06 2010-06-23 Yale University Homologos del receptor de nogo.
US20020111302A1 (en) * 2000-11-30 2002-08-15 Y. Tom Tang Novel nucleic acids and polypeptides
AU2003224950B2 (en) 2002-04-09 2006-09-14 Biogen Ma Inc. Methods for treating tweak-related conditions
CA2391438A1 (en) * 2002-05-01 2003-11-01 Procyon Biopharma Inc. Psp94 diagnostic reagents and assays
US7294704B2 (en) 2003-08-15 2007-11-13 Diadexus, Inc. Pro108 antibody compositions and methods of use and use of Pro108 to assess cancer risk
AU2006214179A1 (en) 2005-02-17 2006-08-24 Biogen Idec Ma Inc. Treating neurological disorders
WO2006122187A2 (en) 2005-05-10 2006-11-16 Biogen Idec Ma Inc. Treating and evaluating inflammatory disorders
WO2006138219A2 (en) 2005-06-13 2006-12-28 Biogen Idec Ma Inc. Methods of diagnosis / prognosis of inflammatory conditions
EP1904091A4 (en) 2005-07-07 2009-12-23 Univ Yale COMPOSITIONS AND METHODS FOR SUPPRESSING THE INHIBITION OF AXON GROWTH
DK2500030T4 (en) 2005-11-04 2018-10-29 Genentech Inc Use of complement pathway inhibitors for the treatment of eye diseases
US8524454B2 (en) 2006-04-07 2013-09-03 The Research Foundation Of State University Of New York Transcobalamin receptor polypeptides, nucleic acids, and modulators thereof, and related methods of use in modulating cell growth and treating cancer and cobalamin deficiency
US9044461B2 (en) 2006-04-07 2015-06-02 The Research Foundation Of State University Of New York Transcobalamin receptor polypeptides, nucleic acids, and modulators thereof, and related methods of use in modulating cell growth and treating cancer and cobalamin deficiency
US7776573B2 (en) 2006-06-01 2010-08-17 Genentech, Inc. Crystal structure of CRIg and C3b:CRIg complex
CN106084055A (zh) 2006-11-02 2016-11-09 健泰科生物技术公司 人源化的抗‑d因子抗体
AR066660A1 (es) 2007-05-23 2009-09-02 Genentech Inc Prevencion y tratamiento de condiciones del ojo asociadas con su complemento
CR20170001A (es) 2008-04-28 2017-08-10 Genentech Inc Anticuerpos anti factor d humanizados
HRP20161580T1 (hr) 2008-05-06 2016-12-30 Genentech, Inc. CRIg-VARIJANTE S RAZVIJENIM AFINITETOM
US9120858B2 (en) 2011-07-22 2015-09-01 The Research Foundation Of State University Of New York Antibodies to the B12-transcobalamin receptor
MX2016001854A (es) 2013-08-12 2016-09-06 Genentech Inc Composiciones y metodo para tratar condiciones asociadas con el complemento.
SG11201608868PA (en) 2014-05-01 2016-11-29 Genentech Inc Anti-factor d antibody variants and uses thereof
TW201730211A (zh) 2015-10-30 2017-09-01 建南德克公司 抗因子d抗體及結合物
JP2018536650A (ja) 2015-10-30 2018-12-13 ジェネンテック, インコーポレイテッド 抗d因子抗体変異体コンジュゲート及びその使用
CN114835774B (zh) * 2022-06-29 2022-09-27 中国农业大学 辣椒籽分离的寡肽msl及其在预防或治疗癌症中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ226799A (en) * 1987-11-06 1991-08-27 Oncogen Breast cancer inhibitory factor and method for inhibiting proliferation of neoplastic cells and compositions therefor
US5814307A (en) * 1989-04-10 1998-09-29 Bristol-Myers Squibb Company Method for regulating cell growth, leukocyte differentiation and tumor cell growth using Oncostatin M to stimulate synthesis of IL-6
US5416192A (en) * 1990-04-03 1995-05-16 Bristol-Myers Squibb Company Epithelins: novel cysteine-rich growth modulating proteins
US5028099A (en) * 1990-08-08 1991-07-02 Bertucco Leonard J Trash recycling container
US6030831A (en) * 1997-09-19 2000-02-29 Genetech, Inc. Tie ligand homologues
WO1999055869A1 (en) * 1998-04-27 1999-11-04 Zymogenetics, Inc. Novel polypeptide growth factors and materials and methods for making them
SV1999000069A (es) * 1998-06-02 2000-04-11 Lilly Co Eli Angiopoyetina relacionada con secuencia del gen 3 en la cicatrizacion de la cara ref. x-12261
JP7039446B2 (ja) * 2018-11-29 2022-03-22 株式会社東芝 電子装置

Similar Documents

Publication Publication Date Title
JP2003524387A5 (cg-RX-API-DMAC7.html)
Lin et al. Cloning, mapping, and characterization of the human sorbin and SH3 domain containing 1 (SORBS1) gene: a protein associated with c-Abl during insulin signaling in the hepatoma cell line Hep3B
Kalikin et al. Genomic and expression analyses of alternatively spliced transcripts of the MLL septin-like fusion gene (MSF) that map to a 17q25 region of loss in breast and ovarian tumors
JP2004522402A5 (cg-RX-API-DMAC7.html)
Nomura et al. Prediction of the coding sequences of unidentified human genes. I. The coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by analysis of randomly sampled cDNA clones from human immature myeloid cell line KG-1
Mink et al. A novel human gene (SARM) at chromosome 17q11 encodes a protein with a SAM motif and structural similarity to Armadillo/β-catenin that is conserved in mouse, Drosophila, and Caenorhabditis elegans
Nakata et al. Fusion of a novel gene, ELKS, to RET due to translocation t (10; 12)(q11; p13) in a papillary thyroid carcinoma
WO1993015201A1 (en) Novel protein tyrosine kinases
Wicki et al. Characterization of the Human and Mouse cDNAsCoding for S100A13, a New Member of the S100 Protein Family
WO2001057278A2 (en) Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human hela cells or other human cervical epithelial cells
de Conciliis et al. Characterization ofCxorf5 (71-7A), a novel human cDNA mapping to Xp22 and encoding a protein containing coiled-coil α-helical domains
Roebroek et al. cDNA Cloning, Genomic Organization, and Expression of the HumanRTN2Gene, a Member of a Gene Family Encoding Reticulons
Sood et al. Cloning and characterization of 13 novel transcripts and the human RGS8 gene from the 1q25 region encompassing the hereditary prostate cancer (HPC1) locus
Koesters et al. Human eukaryotic initiation factor EIF2C1 gene: cDNA sequence, genomic organization, localization to chromosomal bands 1p34–p35, and expression
Wang et al. Cloning of a rat cDNA encoding a novel LIM domain protein with high homology to rat RIL
Enklaar et al. Mtr1, a novel biallelically expressed gene in the center of the mouse distal chromosome 7 imprinting cluster, is a member of the Trp gene family
Albertsen et al. Sequence, genomic structure, and chromosomal assignment of human DOC-2
Takenoshita et al. The genomic structure of the gene encoding the human transforming growth factor β type II receptor (TGF-β RII)
Futamura et al. Molecular cloning, mapping, and characterization of a novel human gene, MTA1-L1, showing homology to a metastasis-associated gene, MTA1
WO2001083739A2 (en) Human pellino polypeptides
Jurecic et al. Identification and cloning of differentially expressed genes by long-distance differential display
US20030165864A1 (en) Genes regulated by DNA methylation in tumor cells
JP2002513276A (ja) S―アデノシル―l―ホモシステイン加水分解酵素(ahcy)型活性を有する酵素
Baens et al. Isolation and regional assignment of human chromosome 12p cDNAs
Godley et al. TTID: A novel gene at 5q31 encoding a protein with titin-like features